Filing Details
- Accession Number:
- 0000929638-23-001625
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-01 16:01:20
- Reporting Period:
- 2023-05-30
- Accepted Time:
- 2023-06-01 16:01:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1831868 | Seastar Medical Holding Corp | ICU | Surgical & Medical Instruments & Apparatus (3841) | 853681132 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1949950 | Kevin Chung | C/O Seastar Medical Holding Corporation 3513 Brighton Blvd., Suite 410 Denver CO 80216 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2023-05-30 | 5,093 | $0.47 | 60,675 | No | 4 | P | Direct | |
Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2023-05-30 | 4,000 | $0.48 | 64,675 | No | 4 | P | Direct | |
Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2023-05-30 | 2,300 | $0.48 | 66,975 | No | 4 | P | Direct | |
Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2023-05-30 | 1,150 | $0.48 | 68,125 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | $1.84 | 2033-04-06 | 66,483 | 66,483 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2033-04-06 | 66,483 | 66,483 | Direct |
Footnotes
- Includes 44,322 shares of the Issuer's common stock subject to restricted stock units (RSUs), all of which will vest, subject to continued service, on April 6, 2024.
- All options reported herein will vest, subject to continued service, on the first anniversary of the date of grant.